---
title: "Indivior (INDV) Receives a Buy from Craig-Hallum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293184801.md"
description: "Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Indivior (INDV) in a July 16 report. The stock closed at $40.59. Indivior holds a Strong Buy consensus with an average price target of $51.00."
datetime: "2026-07-20T08:26:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293184801.md)
  - [en](https://longbridge.com/en/news/293184801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293184801.md)
generator: "portal-rs"
---

# Indivior (INDV) Receives a Buy from Craig-Hallum

In a report released on July 16, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Indivior. The company’s shares closed last Friday at $40.59.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Knickerbocker covers the Healthcare sector, focusing on stocks such as Xeris Pharmaceuticals, MiMedx Group, and Butterfly Network. According to TipRanks, Knickerbocker has an average return of 36.8% and a 61.74% success rate on recommended stocks. 

Indivior has an analyst consensus of Strong Buy, with a price target consensus of $51.00.

### Related Stocks

- [INDV.UK](https://longbridge.com/en/quote/INDV.UK.md)
- [INDV.US](https://longbridge.com/en/quote/INDV.US.md)
- [XERS.US](https://longbridge.com/en/quote/XERS.US.md)
- [MDXG.US](https://longbridge.com/en/quote/MDXG.US.md)
- [BFLY.US](https://longbridge.com/en/quote/BFLY.US.md)
- [BFLY+.US](https://longbridge.com/en/quote/BFLY+.US.md)
- [BFLYW.US](https://longbridge.com/en/quote/BFLYW.US.md)

## Related News & Research

- [Top Indivior Insider Quietly Ramps Up Stake in Bold New Move](https://longbridge.com/en/news/297262729.md)
- [SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders](https://longbridge.com/en/news/297401736.md)
- [Barclays Sticks to Their Buy Rating for Ulta Beauty (ULTA)](https://longbridge.com/en/news/297306719.md)
- [Indivior Chief Accounting Officer Woodrow D Anderson acquires 1,500 shares worth $54,420](https://longbridge.com/en/news/295014018.md)
- [Truist Financial Reaffirms Their Buy Rating on Rubrik, Inc. Class A (RBRK)](https://longbridge.com/en/news/297320868.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**